Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page
- Check4 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling at this time. The Intervention/Treatment heading has been standardized from 'Intervention / Treatment' and the page revision is now listed as v3.6.0.SummaryDifference0.3%

- Check11 days agoChange DetectedThis update adds the ADAPT Study Group publication citation to the Publications section and changes the revision version from v3.5.4 to v3.5.5.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new citation for the ADAPT Lancet Neurology 2021 paper was added to Publications, and the previous citation referencing an Erratum was removed, indicating an update to the study's referenced literature.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s displayed release/version number was updated from v3.5.2 to v3.5.3, reflecting a site maintenance or software revision rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check61 days agoChange DetectedPublications section updated to revision v3.5.2, replacing the previous v3.5.0 entry.SummaryDifference0.1%

- Check83 days agoChange DetectedExpanded Access availability notice added; trial site location name updated from Napoli to Naples, Italy 80131.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.